Contribution to the concept of polypharmacy II. Prescription and use of medicines

1. Kolář J., Ambrus T., Grega T., Smejkalová L. Příspěvek k pojmu polypragmazie. I. Etymologické poznámky a charakteristika. Čes. slov. Farm. 2022; 71, 245–250.

2. Social prescribing. https://www.england.nhs.uk/personalisedcare/ social-prescribing/

3. Islam M. M. Social Prescribing – An Effort to Apply a Common Knowledge: Impelling Forces and Challenges. Front Public Health 2020; 8, 515469

4. What is social prescribing? https://www.kingsfund.org. uk/publications/social-prescribing

5. Bickerdike L., Booth A., Wilson P. M., Farley K., Wright K. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7, e013384.

6. Report of the annual social prescribing network conference. (2016). London: University of Westminster, Wellcome Trust, & College of Medicine.

7. Roberts N. Plan to expand social prescribing in bid to tackle health inequalities. https://www.gponline.com/ plan-expand-social-prescribing-bid-tackle-health-inequalities/ article/1442837

8. De Medicina. Celsus. W. G. Spencer ed. Cambridge, Massachusetts. Harvard University Press. 1971 (Republication of the 1935 edition).

9. Maxwell S. R. J. Rational prescribing: the principles of drug selection. Clin. Med. (Lond) 2016; 16(5), 459–464.

10. De Vries T. P. G. M., Henning R. H., Hogerzeil Hans V., Fresle D. A. WHO Action Programme on Essential Drugs. et al. (1994). Guide to Good Prescribing: A practical manual/ authors: T. P. G. M. de Vries ... [et al.]; with contributions from F. M. Haaijer-Ruskamp and R. M. van Gilst. World Health Organization.

11. World Health Organization (2001). Teacher’s guide to good prescribing. Hans V. Hogerzeil (editor) ... [et al.]. World Health Organization.

12. Ten Principles of Good Prescribing. https://www.bps. ac.uk/education-engagement/teaching-pharmacology/ ten-principles-of-good-prescribing

13. Aronson J. K. Rational prescribing, appropriate prescribing. Br. J. Clin. Pharmacol. 2004; 57(3), 229–230.

14. Buetow S. A., Sibbald B., Cantrill J. A., Halliwell S. Appropriateness in health care: application to prescribing. Soc. Sci. Med. 1997; 45(2), 261–271.

15. Aronson J. K. Balanced prescribing. Br. J. Clin. Pharmacol. 2006; 62(6), 629–632.

16. Aronson J. K. Balanced prescribing – principles and challenges. Br. J. Clin. Pharmacol. 2012; 74(4), 566–572.

17. Ofori-Asenso R., Agyeman A. A. Irrational Use of Medicines – A Summary of Key Concepts. Pharmacy (Basel) 2016; 4(4), 35.

18. Pojem suboptimální. https://slovnik-cizich-slov.abz.cz/ web.php/slovo/suboptimalni

19. Blanco-Reina E., Ariza-Zafra G., Ocaña-Riola R., León-Ortíz M., Bellido-Estévez I. Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related? Eur. J. Clin. Pharmacol. 2015; 71(2), 199–207.

20. Hanlon J. T., Schmader K. E., Ruby C. M., Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J. Am. Geriatr. Soc. 2001; 49(2), 200–209.

21. Cherubini A., Corsonello A., Lattanzio F. Underprescription of Beneficial Medicines in Older People. Causes, Consequences and Prevention. Drugs Aging 2012; 29(6), 443–475.

22. Montamat S. C., Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin. Geriatr. Med. 1992; 8(1), 143–158.

23. Lee G. B., Etherton-Beer Ch., Hosking S, M., Pasco J. A., Page A. T. The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review. Ther. Adv. Drug Saf. 2022; 13, 1–41.

24. Baltasar Gracián. https://www.goodreads.com/author/ show/1026409.Baltasar_Graci_n

25. The Art of Worldly Wisdom. https://en.wikipedia.org/ wiki/The_Art_of_Worldly_Wisdom

26. Government pledges to reduce overprescribing of medicines. https://www.gov.uk/government/news/government- pledges-to-reduce-overprescribing-of-medicines

27. Ogden J. NHS overprescribing: the national review recommendations. Prescriber 2022; 33(2), 35–38.

28. Good for you, good for us, good for everybody. A plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions. Department of Health & Social Care, 2021

29. Kuijpers M. A. J., van Marum R. J., Egberts A. C. G., Jansen P. A. F. Relationship between polypharmacy and underprescribing. Br. J. Clin. Pharmacol. 2008; 65(1), 130–133.

30. Lipton H. L., Bero L. A., Bird J. A., McPhee S. J. Undermedication among geriatric outpatients: results of a randomized controlled trial. Ann. Rev. Gerontol. 1992; 12, 95–108.

31. Barry P. J., Gallagher P., Ryan C., O’Mahony D. START (screening tool to alert doctors to the right treatment) – an evidence-based screening tool to detect prescribing omissions in elderly patients. Age and Ageing 2007; 36(6), 632–638.

32. O’Mahony D., Gallagher P. F. Inappropriate prescribing in the older population: need for new criteria. Age and ageing 2008; 37(2), 138–141.

33. Dineen K. K. Defining Misprescribing to Inform Prescription Opioid Policy. The Hastings Center Report 2018; 48(4), 5–6.

34. San-José A., Agustí A., Vidal X., Formiga F., López-Soto A., Fernández-Moyano A., García J., Ramírez-Duque N. Torres O. H., Barbé J. Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing. Eur. J. Intern. Med. 2014; 25(8), 710–716.

35. Woodward M. C. Deprescribing: achieving better health outcomes for older people through reducing medications. J. Pharm. Pract. Res. 2003; 33(4), 323–328.

36. Alldred D. P. Deprescribing: a brave new word? J. Pharm. Pract. Res. 2014; 22(1), 2–3.

37. Halli-Tierney A. D., Scarbrough C., Carroll, D. Polypharmacy: Evaluating Risks and Deprescribing. Am. Fam. Physician 2019; 100(1), 32–38.

38. What is Deprescribing? https://deprescribing.org/what -is-deprescribing/

39. Scott I. A., Hilmer S. N., Reeve E., Potter K., Le Couteur D., Rigby D., Gnjidic D., Del Mar C. B., Roughead E. E., Page A., Jansen J., Martin J. H. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern. Med. 2015; 175(5), 827–834.

40. Medication management – deprescribing. https://www. primaryhealthtas.com.au/resources/deprescribingresources/

41. Coggins M. D. Deprescribing Improves Quality of Life. Today’s Geriatric Medicine 2017; 10(4), 8.

42. Scott I. A., Gray L. C., Martin J. H., Pillans P. I., Mitchell C. A. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid. Based Med. 2013; 18(4), 121–124.

43. Tenni P., Dunbabin, D. A guide to deprescribing. 2019, 8. https://www.primaryhealthtas.com.au/wp-content/ uploads/2018/09/General-information-fact-sheet.pdf

44. Pruskowski J. A., Springer S., Thorpe C. T., Klein-Fedyshin S., Handler S. M. Does Deprescribing Improve Quality of Life? A Systematic Review of the Literature. Drugs & Aging 2019; 36(862), 1097–1110.

45. Hanousková K., Neumannová J. Možnosti spolupráce nemocničního paliativního týmu s praktickým lékařem aneb jak vám můžeme pomoci. Practicus 2022; 21(6), 23–25.

46. Kolář J., Ambrus T., Grega D., Smejkalová L. Příspěvek k problematice polypragmazie. Depreskripce – praktické nástroje. Farm. Obzor 2022; 91(5), 109–117.

47. Herophilos Quote. https://libquotes.com/herophilos/ quote/lbb0b0t

48. The rational use of drugs: report of the conference of experts Nairobi, 25–29 November 1985. Geneva: World Health Organization 1987.

49. WHO Policy Perspectives on Medicines. 5. Promoting rational use of medicines: core components. WHO/ EDM/2002.3

50. Promoting rational use of medicines. https://www. who.int/activities/promoting-rational-use-of-medicines/

51. Almarsdóttir A. B., Traulsen J. M. Rational use of medicines – an important issue in pharmaceutical policy. Pharm. World Sci. 2005; 27(2), 76–80.

52. May F. Whither ‘Rational’ Use of Drugs? J. Pharm. Pract. Res. 2008; 38(2), 89–91.

53. Orive G., Domingo-Echaburu S., Lertxundi U. Redefining the “rational use of medicines”. Sustain. Chem. Pharm. 2021; 20(4), 100381.

54. Lertxundi U., Domingo-Echaburu S., Orive G. Rational use of drugs as a source control measure to fight drug pollution. J. Hazard Mater. 2021; 410, 124664.

55. Abiye A. A., Kedir H. M., Salile S. S., Woldamo B. A., Ali H. S., Berhe A. B. Rational Drug Use in a Rural Area of Ethiopia: Based on WHO/INRUD Prescribing Indicators. J Basic Clin Pharma 2021;12(7), 104–108.

56. Holloway K., van Dijk L. The World Medicines Situation 2011 Rational Use of Medicines 3rd Edition WHO/EMP/ MIE/2011.2.2

57. Conference of Experts on the Rational Use of Drugs (Nairobi, Kenya: 1985) & World Health Organization. Action Programme on Essential Drugs and Vaccines. (1985). The Rational use of drugs: review of major issues. World Health Organization. https://apps.who.int/iris/handle/10665/62311

58. Kaczmarek E. How to distinguish medicalization from over-medicalization? Medicine, Health Care and Philosophy 2019; 22(1), 119–128.

59. Bártlová S. Proces medicinalizace. Kontakt 2006; 8(2), 280–285.

60. Piau A., Hein C., Nourhashemi F., Sebbagh M., Legrain S. Omission de traitement chez la personne âgée: quelle définition pour quels enjeux? Geriatr. Psychol. Neuropsychiatr. Vieil. 2012; 10(2), 129–135.

61. Lexicon of alcohol and drug terms. WHO 1994

62. What is drug abuse and misuse? https://short-facts.com/ what-is-drug-abuse-and-misuse/

63. Alušík, Š., Paluch, Z. Úskalí řešení problémů polymedikace. Vnitř. Lék. 2021; 67(1), 22–25.

64. Masnoon N., Shakib S., Kalisch-Ellett L., Caughey G. E. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; 17(1), 230.